Craig Gelfand
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$6.8MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $6.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 7, 2025 | NIH | SBIR Phase II Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation | $993K | ADVENT THERAPEUTICS INC |
| Mar 22, 2024 | NIH | SBIR Phase II Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation | $994K | ADVENT THERAPEUTICS INC |
| Mar 20, 2023 | NIH | SBIR Phase II Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation | $995K | ADVENT THERAPEUTICS INC |
| Mar 20, 2023 | NIH | SBIR Phase II Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation | $995K | ADVENT THERAPEUTICS INC |
| Aug 3, 2021 | NIH | SBIR Phase II Aerosolized Vitamin A: Impact on Neonatal Lung Maturation, Hyperoxic Lung Injury and Bronchopulmonary Dysplasia | $1.3M | ADVENT THERAPEUTICS INC |
| Aug 13, 2020 | NIH | SBIR Phase II Aerosolized Vitamin A: Impact on Neonatal Lung Maturation, Hyperoxic Lung Injury and Bronchopulmonary Dysplasia | $1.1M | ADVENT THERAPEUTICS INC |
| Jul 1, 2018 | NIH | SBIR Phase I Aerosolized vitamin A impact on lung maturation and hyperoxic neonatal lung injury | $225K | ADVENT THERAPEUTICS INC |
| Jun 25, 2018 | NIH | SBIR Phase I Aerosolized vitamin A impact on lung maturation and hyperoxic neonatal lung injury | $225K | ADVENT THERAPEUTICS INC |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#159
Awards as PI#216
Patents#505
Companies
- ADVENT THERAPEUTICS INCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.